Market Access & Reimbursement

United States takes 1/3 of the global healthcare market, which is estimated to be 1.48 trillion U.S. dollars. However, the U.S. health policy landscape is rapidly evolving, with significant changes such as the Inflation React Act (IRA) empowering public payers to negotiate drug prices, and a major overhaul of Pharmacy Benefit Managers (PBM) and pharmacy operation models. To navigate these complexities, we collaborate with our partners to assist both large and small biopharmaceutical and medical device companies worldwide in planning their market access and reimbursement strategies. Our goal is to ensure that these companies are well-positioned to succeed in this dynamic and highly competitive market.

Our Insights on Data, Technology, and Healthcare
Is Life Science Ready for AI?
Jan 02, 2025
A few days ago, Dr. Geoffrey Hinton, often referred to as the “Godfather of AI,” made a chilling statement: “There is a 10-20 percent probability that...
Read more
Polygon Health Analytics Receives Competitive SBIR Grant from NIMHD to Address Health Disparities in Lupus Care
Nov 20, 2024
Philadelphia, PA — Nov 19, 2024 — Polygon Health Analytics LLC is proud to announce its award of a $295,924 Small Business Innovation Research (SBIR) Phase I...
Read more
View all